More states back $7.4 billion Purdue Pharma opioid settlement
More states, territories and Washington, D.C., have signed on to a settlement with drugmaker Purdue Pharma and the Sackler family over the opioid crisis, officials said.
Sackler Family
Inside the Purdue Pharma bankruptcy case
Here's why people alleging Purdue Pharma's opioids harmed them may not see much of the proposed $7.4 billion settlement in a bankruptcy case
Claimant: Opioid victims not getting justice in proposed Purdue settlement
Here's why people alleging Purdue Pharma's opioids harmed them may not see much of the proposed $7.4 billion settlement in a bankruptcy case.
Potential $7.4B Purdue Pharma opioid settlement frustrates some victims
Opioid victims are not getting a "fair shake" in potential $7.4 billion settlement, a claimant in the Purdue Pharmacy bankruptcy case says.
Sacklers, Purdue Pharma reach $7.4B settlement with 15 states over opioid crisis
The Sackler family will pay the vast majority of the settlement — a total of $6.5 billion over 15 years.
Supreme Court rulings for FDA, Purdue Pharma
In two rulings released Thursday, the Supreme Court has blocked both the EPA good neighbor rule meant to fight air pollution and Purdue Pharma's bankruptcy plan that would've broadly protected the Sackler family from civil lawsuits related to their role in the opioid epidemic. Former federal prosecutor Scott Fredericksen joined CBS News to discuss the decisions.
Supreme Court weighs legal shield for Sacklers
The Supreme Court heard arguments Monday in a case over a settlement for victims of the opioid crisis. Approving the settlement would mean shielding the Sackler family, the former owners of Purdue Pharma, from future lawsuits. Jan Crawford reports.
Purdue Pharma bankruptcy shielding Sackler family heads to Supreme Court
Purdue Pharma, the maker of OxyContin, filed for Chapter 11 bankruptcy protection in September 2019 after it faced scores of lawsuits related to the opioid crisis.
Supreme Court weighs Purdue Pharma bankruptcy
The U.S. Supreme Court will hear oral arguments Monday about the legality of a $6 billion bankruptcy agreement for Purdue Pharma, the manufacturer of OxyContin. While many families of victims support the deal, which would fulfill financial settlements, it would shield the powerful Sackler family from thousands of potential lawsuits. CBS News' Jan Crawford reports.
Opioid settlement challenge in Supreme Court
A multibillion-dollar bankruptcy settlement with the maker of Oxycontin will be challenged Monday at the Supreme Court. Justices are weighing whether the wealthy Sackler family, which owned Purdue Pharma, can evade lawsuits over the company's powerful painkillers linked to hundreds of thousands of deaths. CBS News chief legal correspondent Jan Crawford reports.
Purdue Pharma settlement put on hold
The Supreme Court put a settlement by Purdue Pharma on hold Friday. The settlement would have shielded the Sackler family, the clan behind the company and its alleged role in the opioid crisis, from future civil litigation. Jeff Glor has more.
Supreme Court blocks Purdue Pharma settlement
The Supreme Court has temporarily blocked a Purdue Pharma settlement that would shield the Sackler family from civil lawsuits related to the opioid crisis. Author Barry Meier, who wrote the book "Pain Killer" about the Sacklers and Purdue Pharma, weighs in on the settlement.
Judge rejects Purdue Pharma's sweeping opioid settlement
Purdue sought bankruptcy protection in 2019 as it faced thousands of lawsuits over its drug OxyContin.
Judge OK's controversial Purdue Pharma opioid settlement
Under the settlement, the Sackler family will give up ownership of the company and contribute $4.5 billion, but will be freed from any future lawsuits over opioids.
Decision expected in pharma bankruptcy settlement
A New York judge is expected to decide today whether to approve a bankruptcy settlement from oxycontin maker Purdue Pharma. The drug company and members of the family that own it, the Sacklers, have been blamed by some for helping fuel the country's opioid crisis. It's been linked to about 500,000 deaths nationwide. Anna Werner reports.
Former head of OxyContin maker denies blame for opioid crisis
Richard Sackler questioned in court over whether his family bears any responsibility for drug epidemic.
Sackler family members and the opioid crisis
The Sackler family, one of the wealthiest in America, has long been known as a patron of the arts, but only recently did their connections to Purdue Pharma become widely known. The company, which some blame for helping spark the opioid crisis, is privately owned by some members of the family. "48 Hours" correspondent Erin Moriarty reports on the Sacklers, whose name has become a controversial flashpoint in the opioid epidemic, and talks with New Yorker staff writer Patrick Radden Keefe, author of "Empire of Pain: The Secret History of the Sackler Dynasty."
Some members of Sackler family under fire over ties to opioids
Purdue Pharma, which some blame for helping spark the opioid crisis, is privately owned by some members of the Sackler family, whose name has become a controversial flashpoint in the opioid epidemic.
Purdue Pharma proposes $10 billion plan to come out of bankruptcy
OxyContin maker would put profits into fight against opioid crisis, but many state attorneys general say plan doesn't do enough for victims and their families.
Purdue Pharma files for bankruptcy
Purdue Pharma, the company that made billions selling the prescription painkiller OxyContin, filed for bankruptcy late Sunday. The move came days after Purdue reached a tentative settlement with many state and local governments over the toll the opioid epidemic has taken on communities nationwide.
Sacklers cashed out $10.4 billion from Purdue Pharma in last decade
Analysis commissioned by bankruptcy court could fuel calls for Sackler family members to return their drug windfall.
Purdue Pharma to stay in business as it pursues bankruptcy protection
Lawyers for the pharmaceutical company secured permission to maintain business as usual — paying employees and vendors, supplying pills to distributors and keeping current on taxes and insurance
Even with bankruptcy, Purdue Pharma may not be off the hook
Some states plan to object to a settlement in bankruptcy court and may pursue lawsuits against the Sackler family
Purdue Pharma files for bankruptcy
Move was expected as part of landmark settlement with many state and local governments of lawsuit over toll opioid crisis has taken on nation
Sackler family could pay billions in personal wealth to settle opioid lawsuits
Purdue Pharma, the maker of Oxycontin, is accused of fueling the opioid crisis
California couple at center of surrogacy scandal arrested
Live
Iran's Houthi allies deny losing ground as Mideast crisis engulfs Yemen
What to know about plague amid reports of worker death at Russian lab
Olympian accused of damaging Reflecting Pool seeks probe of potential misconduct
French high schools closed in biggest day of student protests in decades
Ex-CIA official found with $40 million in gold bars admits to sprawling scheme
Exclusive
Former Cornell frat members ask university to clear their names
Trump suggests letting Iran "take out" LA, San Diego during rally
